![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Erietta Polychronopoulou, Gregoire Wuerzner & Michel Burnier. (2021) How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice. Vascular Health and Risk Management 17, pages 1-11.
Read now
Read now
Enrico Agabiti Rosei. (2016) The fixed-dose combination of lercanidipine and enalapril: more than mere blood pressure reduction. Current Medical Research and Opinion 32:sup2, pages 1-2.
Read now
Read now
Nicolas Roberto Robles, Carlos Calvo, Javier Sobrino, Eugenia Espinel, Rafael Esteban, Lourdes Mateos & Juan F Macias. (2016) Lercanidipine valuable effect on urine protein losses: the RED LEVEL study. Current Medical Research and Opinion 32:sup2, pages 29-34.
Read now
Read now
Gianfranco Parati. (2016) Vascular effects of the lercanidipine/enalapril combination: clinical relevance. Current Medical Research and Opinion 32:sup2, pages 25-28.
Read now
Read now
Xiongjing Jiang, Meng Peng, Bin Li, Hui Dong, Wuqiang Che, Yubao Zou, Yuejin Yang & Runlin Gao. (2016) The efficacy of renal artery stent combined with optimal medical therapy in patients with severe atherosclerotic renal artery stenosis. Current Medical Research and Opinion 32:sup2, pages 3-7.
Read now
Read now
Zhengyu Yang. (2015) Efficacy and safety evaluation of perindopril–lercanidipine combined therapy in patients with mild essential hypertension. Current Medical Research and Opinion 31:1, pages 183-186.
Read now
Read now
Meng Peng, Xiong-jing Jiang, Hui Dong, Yu-bao Zou, Hui-min Zhang, Hai-ying Wu & Yuejin Yang. (2015) Can lercanidipine improve renal function in patients with atherosclerotic renal artery stenosis undergoing renal artery intervention?. Current Medical Research and Opinion 31:1, pages 177-182.
Read now
Read now
Articles from other publishers (3)
Eun Mi Lee. (2023) Calcium channel blockers for hypertension: old, but still useful. Cardiovascular Prevention and Pharmacotherapy 5:4, pages 113-125.
Crossref
Crossref
Alexander Schütze, Peter Benöhr, Marion Haubitz, Roland Radziwill & Carina Hohmann. (2023) Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease. European Journal of Hospital Pharmacy 30:1, pages 46-52.
Crossref
Crossref
Estela Hanauer Schaab, Vera Lucia Lanchote, Glauco Henrique Balthazar Nardotto, Maria Paula Marques Pereira, Márcio Dantas, Carlos Eduardo Paiva & Eduardo Barbosa Coelho. (2019) Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease. The Journal of Clinical Pharmacology 60:1, pages 75-85.
Crossref
Crossref